Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vincent

Showing results (731-740 of 764) with videos related to

Pageof 77
Sort By:
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Critical Care Medicine|December 26, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Intensive Care Medicine|December 15, 2021
Current practice and evolving concepts in septic shock resuscitationJan Bakker, Eduardo Kattan, Djillali Annane, et al.
Intensive Care Medicine|November 14, 2025
ESICM guidelines on circulatory shock and hemodynamic monitoring 2025Xavier Monnet, Antonio Messina, Massimiliano Greco, et al.
Shock (Augusta, Ga.)|February 27, 2014
Abandon the mouse research ship? Not just yet!Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational studyGiacomo Grasselli, Tommaso Tonetti, Alessandro Protti, et al.
The Lancet. Respiratory Medicine|February 26, 2024
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesManu Shankar-Hari, Thierry Calandra, Miguel P Soares, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
JAMA|October 9, 2024
Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury: The TRAIN Randomized Clinical TrialFabio Silvio Taccone, Carla Bittencourt Rynkowski, Kirsten Møller, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Pageof 77

Showing results (731-740 of 764) with videos related to

Sort By:
Pageof 77
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Critical Care Medicine|December 26, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Intensive Care Medicine|December 15, 2021
Current practice and evolving concepts in septic shock resuscitationJan Bakker, Eduardo Kattan, Djillali Annane, et al.
Intensive Care Medicine|November 14, 2025
ESICM guidelines on circulatory shock and hemodynamic monitoring 2025Xavier Monnet, Antonio Messina, Massimiliano Greco, et al.
Shock (Augusta, Ga.)|February 27, 2014
Abandon the mouse research ship? Not just yet!Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational studyGiacomo Grasselli, Tommaso Tonetti, Alessandro Protti, et al.
The Lancet. Respiratory Medicine|February 26, 2024
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesManu Shankar-Hari, Thierry Calandra, Miguel P Soares, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
JAMA|October 9, 2024
Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury: The TRAIN Randomized Clinical TrialFabio Silvio Taccone, Carla Bittencourt Rynkowski, Kirsten Møller, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Pageof 77